PTC Therapeutics Says European Commission Returns Translarna Opinion To CHMP For Re-evaluation

RTTNews | 915 hari yang lalu
PTC Therapeutics Says European Commission Returns Translarna Opinion To CHMP For Re-evaluation

(RTTNews) - PTC Therapeutics, Inc. (PTCT) announced Monday that the European Commission (EC) has decided not to adopt the CHMP's negative opinion of January 24, 2024 on the annual renewal of the conditional marketing authorization of Translarna (ataluren) and has returned the opinion to the CHMP for re-evaluation.

As a result, Translarna remains on the market and available for patients in Europe consistent with its current marketing authorization. The EC has asked the CHMP to further consider the totality of evidence, including data from patient registries and real-world evidence, in a revised opinion.

In addition, the European Medicines Agency (EMA) has informed PTC that the decision has been taken to consider the Scientific Advisory Group (SAG) meeting for Translarna held on September 5, 2023, and all the procedural steps that followed, as invalid.

Furthermore, the input from the SAG meeting held in September 2023 as well as the meeting held in January 2024 will not be considered by the CHMP in any future evaluation of Translarna.

Given the inability to accurately forecast the upside impact of the continued authorization of Translarna in Europe on 2024 revenue, PTC will pause 2024 total revenue guidance at this time.

baca selengkapnya
FDA Approves PTC's Kebilidi As First Gene Therapy To Treat AADC Deficiency

FDA Approves PTC's Kebilidi As First Gene Therapy To Treat AADC Deficiency

The U.S. Food and Drug Administration approved PTC Therapeutics, Inc.'s Kebilidi (eladocagene exuparvovec-tneq) gene therapy for the treatment of aromatic L-amino acid decarboxylase or AADC deficiency. Kebilidi is the first FDA-approved gene therapy for the deficiency. PTC shares gained around 8.5 percent in the extended trading on the Nasdaq on Thursday.
RTTNews | 736 hari yang lalu
PTC Therapeutics Granted Marketing Authorization By EU For Upstaza To Treat AADC Deficiency

PTC Therapeutics Granted Marketing Authorization By EU For Upstaza To Treat AADC Deficiency

PTC Therapeutics, Inc. (PTCT) announced Wednesday that Upstaza (eladocagene exuparvovec) was granted marketing authorization by the European Commission. Upstaza is the first approved disease-modifying treatment for aromatic L-amino acid decarboxylase (AADC) deficiency and the first marketed gene therapy directly infused into the brain. It is approved for patients 18 months and older.
RTTNews | 1585 hari yang lalu
Swiss Market Ends Weak For 4th Straight Session

Swiss Market Ends Weak For 4th Straight Session

The Switzerland market ended weak on Friday, extending recent losses, as rising uncertainty about AI trade and rising cost of debts, as well as fears of possible interest rate hikes by central banks rendered the mood bearish.
RTTNews | 1 hari yang lalu
European Markets Close Notably Lower As AI Trade Concerns Trigger Sell-off

European Markets Close Notably Lower As AI Trade Concerns Trigger Sell-off

European stocks fell on Friday and several markets across the region hit multi-week lows - some markets even dropped to multi-month lows - weighed down by losses in several sectors, especially in the technology space amid uncertainty about the sustainability of AI trade despite Anthropic's historic IPO.
RTTNews | 1 hari yang lalu
TSX Sinks To 6-Month Low As Tech Sector Crumbles

TSX Sinks To 6-Month Low As Tech Sector Crumbles

Canadian equities tumbled Friday as technology stocks plunged 4.4% following global AI trade concerns. The benchmark index dropped 418.25 points to 33,610.48. Materials and financial sectors also declined significantly on weak commodity prices.
RTTNews | 1 hari yang lalu
U.S. Consumer Sentiment Improves More Than Previously Estimated November

U.S. Consumer Sentiment Improves More Than Previously Estimated November

A report released by the University of Michigan on Friday showed consumer sentiment in the U.S. improved by more than previously estimated in the month of November. The University of Michigan said its consumer sentiment index for November was upwardly revised to 51.5 from a preliminary reading of 51.0.
RTTNews | 1 hari yang lalu